Trial NCT02158936

View at ClinicalTrials.gov 
Org. Study IDs: 112121

Last trial update was posted on 2017-12-12

MeSH Interventions

Azacitidine

MeSH Conditions

Myelodysplastic Syndromes Preleukemia Syndrome Thrombocytopenia

Other Conditions

Thrombocytopaenia

Stopping Reasons

N/A

Limitations And Caveats

The IDMC recommended terminating the study for futility (primary) and safety (secondary). Due to early termination of the trial, the final analysis of OS took place at the same time as the final analysis of the primary end point.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID